Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
![Cabozantinib](https://www.biomol.com/media/image/ca/9a/a5/CDX-C0755-M010_600x600.png)
Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
---|---|---|---|---|---|---|---|
CDX-C0755-M010 | 10 mg | - | - |
3 - 9 business days* |
168.00€
|
||
CDX-C0755-M050 | 50 mg | - | - |
3 - 9 business days* |
535.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Cabozantinib is a potent multi-targeted receptor tyrosine kinase (RTK) inhibitor of endothelial... more
Product information "Cabozantinib"
Cabozantinib is a potent multi-targeted receptor tyrosine kinase (RTK) inhibitor of endothelial growth factor receptor 2 (VEGFR2) (IC50=0.035nM), the hepatocyte growth factor receptor c-Met (IC50=1.3nM), AXL (IC50=7nM), fms like tyrosine kinase 3 (FLT3) (IC50=11.3nM), mast/stem cell growth factor (KIT) (IC50=4.6nM), RET (IC50=5.2nM), tyrosine-protein kinase receptor (TIE-2) (IC50=14.3nM) and RON (IC50=124nM). Cabozantinib reduces cell proliferation and vascular density. It also induces apoptosis and intratumoral hypoxia. Cabozantinib exhibits dose-related tumor growth inhibition, tumor regression, angiogenesis and/or metastasis inhibition in a broad range of preclinical tumor models. The anticancer compound cabozantinib has undergone clinical trial in a broad number of cancers, including thyroid carcinoma, prostate cancer, ovarian cancer, melanoma, breast cancer, non-small cell lung cancer, hepatocellular cancer, renal cell carcinoma and glioblastoma. Product References: (1) Y. Zhang, et al., IDrugs 13, 112 (2010) , (2) R. Kurzrock, et al., J. Clin. Oncol. 29, 2660 (2011) , (3) F.M. Yakes, et al., Mol. Canc. Ther. 10, 2298 (2011) , (4) S. Roy, et al., Anticancer Agents Med. Chem. 15, 37 (2015) (Review) , (5) N.M. Tannir, et al., Curr. Oncol. Rep. 19, 14 (2017) (Review) , (6) C. Grullich, Recent Res. Cancer Res. 211, 67 (2018) (Review) , (7) J.N. Markowitz & K.M. Fancher,, Pharmacotherapy 38, 357 (2018) (Review) , (8) A. Desai & E.J. Small, Future Oncol. 15, 2337 (2019) (Review) , (9) J. Trojan, Drugs 80, 1203 (2020) (Review) Appearance: White to off-white solid. Solubility: Soluble in DMSO (20mg/ml). Slightly soluble in ethanol. Identity: Determined by 1H-NMR. InChi Key: ONIQOQHATWINJY-UHFFFAOYSA-N Smiles: O=C(NC1=CC=C(OC2=C3C=C(C(OC)=CC3=NC=C2)OC)C=C1)C4(C(NC5=CC=C(C=C5)F)=O)CC4
Keywords: | BMS-907351, XL184 |
Supplier: | Chemodex |
Supplier-Nr: | C0755 |
Properties
Application: | Potent multi-targeted receptor tyrosine kinase (RTK) inhibitor |
MW: | 501.5 D |
Formula: | C28H24FN3O5 |
Purity: | >98% (HPLC) |
Format: | Solid |
Database Information
CAS : | 849217-68-1| Matching products |
KEGG ID : | K05098 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | +20°C (International: +20°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed